Status:
RECRUITING
Telegenetics or In-Person Genetic Counselling
Lead Sponsor:
National Cancer Centre, Singapore
Conditions:
Genetic Counselling
Eligibility:
All Genders
21+ years
Brief Summary
This study aims to compare clinical outcomes (informed choice and genetic counselling outcomes) and cost (provider and patient time, travel, and telehealth platform) between telegenetics and in-person...
Detailed Description
This study will compare the patient-reported outcomes of telegenetics with in-person consultations for participants considering germline testing for HBOC or Lynch syndrome. It will clarify if telegene...
Eligibility Criteria
Inclusion
- Age ≥ 21 years old.
- Patients referred to CGS at NCCS for HBOC or Lynch syndrome pre-test genetic counselling.
- Able to read and understand the English Language.
- Able to consent and agree to be randomized to either telegenetics or in-person genetic counselling.
Exclusion
- Under the age of 21 years old.
- Patients who require genetic results urgently.
- Cognitive difficulty/ impairment or current psychiatric or physical illness (visual/ hearing/ neurological) which impairs sound judgement and accurate reporting of medical history over video consultation.
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 16 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04738708
Start Date
February 1 2021
End Date
October 16 2025
Last Update
January 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Centre Singapore
Singapore, Singapore, 169610